Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
Edoxaban
Edoxaban
Brand names: Savaysa
| Form | Strength |
|---|---|
| TABLET, ORAL | 15 mg, 30 mg, 60 mg |
Last updated: Nov. 30, 2021
- High Alert: CAUTION: See High-Alert Medication Policy
- Black Box Warning: Reduced efficacy; risk of ischemic events; spinal/epidural hematoma
Non-formulary medication at LHS
Clinical Guidelines Pertain to Patient's Own Medication use for this NON-formulary medication:
Anticoagulation Therapy Management: Policy 900.3207
Initiation/Dosing: Anticoagulation selection for patients with non-valvular atrial fibrillation. See Guideline 900.5008
Initiation/Other: Direct Oral Anticoagulant Use for Venous Thromboembolism, see Protocol 900.5206
Transitioning: Warfarin transition (to or from edoxaban): See Guideline 900.5863
Surgery: Timing of Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5683
Surgery: Periprocedural Management of Anticoagulation therapy: See Protocol 900.5011
Reversal: Reversal in bleeding patients or for emergent surgery: See Reversal Guideline 900.5010
Antithrombotic and Anticoagulant Treatment in Stroke: See 900.5018